LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LENZ Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -82.13 | -49.77 | -69.97 | -10.81 | -7.56 |
| Depreciation & Amortization | 0.29 | 0.06 | 0.02 | 0.01 | 0 |
| Loss (Gain) From Sale of Assets | - | 0.02 | - | - | - |
| Asset Writedown & Restructuring Costs | 0.08 | - | - | - | - |
| Loss (Gain) From Sale of Investments | -3.21 | -5.35 | -1.06 | - | - |
| Stock-Based Compensation | 12.55 | 6.37 | 1.34 | 0.72 | 0.2 |
| Other Operating Activities | - | 1.05 | -0.12 | -0.02 | 0.82 |
| Change in Accounts Receivable | -0.33 | - | - | - | - |
| Change in Inventory | -4.28 | - | - | - | - |
| Change in Accounts Payable | -0.09 | -4.28 | 0.86 | 4.3 | 0.38 |
| Change in Other Net Operating Assets | 7.95 | -7.48 | 8.55 | 1.72 | 0.77 |
| Operating Cash Flow | -69.17 | -59.39 | -60.38 | -4.09 | -5.39 |
| Capital Expenditures | -0.83 | -0.47 | -0.03 | -0.04 | -0.01 |
| Investment in Securities | -74.84 | -154.01 | -29.59 | - | - |
| Investing Cash Flow | -75.67 | -154.48 | -29.62 | -0.04 | -0.01 |
| Issuance of Common Stock | 149.75 | 83.55 | 0.2 | 0.13 | - |
| Other Financing Activities | - | 115.45 | -2.48 | - | - |
| Financing Cash Flow | 149.75 | 199 | 80.7 | 30.26 | 22.77 |
| Net Cash Flow | 4.91 | -14.87 | -9.3 | 26.13 | 17.36 |
| Free Cash Flow | -70 | -59.86 | -60.41 | -4.13 | -5.4 |
| Free Cash Flow Margin | -366.71% | - | - | -27.52% | - |
| Free Cash Flow Per Share | -2.43 | -2.81 | -30.84 | -0.44 | -0.58 |
| Levered Free Cash Flow | -40.25 | -40.65 | -34.21 | 0.1 | - |
| Unlevered Free Cash Flow | -40.25 | -40.65 | -34.21 | 0.1 | - |
| Change in Working Capital | 3.25 | -11.76 | 9.41 | 6.01 | 1.15 |
Source: S&P Capital IQ. Standard template.
Financial Sources.